Health Insurance to Cover Targeted Therapies and Immunotherapies
In a significant shift for public health policy, healthcare regulators are moving to expand the scope of coverage for advanced oncology treatments, signaling a potential turning point for patients navigating complex cancer care. The proposal seeks to integrate a wide array of targeted therapies, immunotherapies, and advanced monoclonal antibodies into the standard catalogue of insured … Read more